Results 11 to 20 of about 3,206,200 (405)

Sprouting Angiogenesis in Human Pituitary Adenomas

Frontiers in Oncology, 2022
IntroductionAngiogenesis in pituitary tumors is not fully understood, and a better understanding could help inform new pharmacologic therapies, particularly for aggressive pituitary tumors.Materials and Methods219 human pituitary tumors and 12 normal ...
Jie Zhou, Yaomin Hu, Wende Zhu, Chuansheng Nie, Wenxiu Zhao, Alexander T. Faje, Kay E. Labelle, Brooke Swearingen, Hang Lee, E. Tessa Hedley-Whyte, Xun Zhang, Pamela S. Jones, Karen K. Miller, Anne Klibanski, Yunli Zhou, Roy J. Soberman   +15 more
doaj   +1 more source

Pilot study to define criteria for Pituitary Tumors Centers of Excellence (PTCOE): results of an audit of leading international centers

Pituitary, 2023
The Pituitary Society established the concept and mostly qualitative parameters for defining uniform criteria for Pituitary Tumor Centers of Excellence (PTCOEs) based on expert consensus.
A. Giustina, M. M. Uygur, S. Frara, A. Barkan, N. Biermasz, P. Chanson, P. Freda, M. Gadelha, U. Kaiser, S. Lamberts, E. Laws, L. Nachtigall, V. Popović, M. Reincke, C. Strasburger, A. J. van der Lely, J. Wass, S. Melmed, F. Casanueva   +18 more
semanticscholar   +1 more source

Costs and Its Determinants in Pituitary Tumour Surgery

Frontiers in Endocrinology, 2022
PurposeValue-based healthcare (VBHC) provides a framework to improve care by improving patient outcomes and reducing healthcare costs. To support value-based decision making in clinical practice we evaluated healthcare costs and cost drivers in ...
Alies J. Dekkers, Alies J. Dekkers, Friso de Vries, Friso de Vries, Amir H. Zamanipoor Najafabadi, Emmy M. van der Hoeven, Marco J. T. Verstegen, Marco J. T. Verstegen, Alberto M. Pereira, Alberto M. Pereira, Alberto M. Pereira, Wouter R. van Furth, Wouter R. van Furth, Nienke R. Biermasz, Nienke R. Biermasz   +14 more
doaj   +1 more source

Imaging of pituitary tumors: an update with the 5th WHO Classifications—part 1. Pituitary neuroendocrine tumor (PitNET)/pituitary adenoma

Japanese Journal of Radiology, 2023
The pituitary gland is the body’s master gland of the endocrine glands. Although it is a small organ, many types of tumors can develop within it. The recently revised fifth edition of the World Health Organization (WHO) classifications (2021 World Health
Taro Tsukamoto, Yukio Miki
semanticscholar   +1 more source

The Upregulation of Molecules Related to Tumor Immune Escape in Human Pituitary Adenomas

Frontiers in Endocrinology, 2021
Human pituitary adenomas are one of the most common intracranial neoplasms. Although most of these tumors are benign and can be treated medically or by transsphenoidal surgery, a subset of these tumors are fast-growing, aggressive, recur, and remain a ...
Zhiyu Xi, Pamela S. Jones, Masaaki Mikamoto, Xiaobin Jiang, Alexander T. Faje, Chuansheng Nie, Kathryn E. Labelle, Yunli Zhou, Karen K. Miller, Roy J. Soberman, Xun Zhang   +10 more
doaj   +1 more source

Expressions of Cushing’s syndrome in multiple endocrine neoplasia type 1

Frontiers in Endocrinology, 2023
Cushing’s syndrome (CS) resulting from endogenous hypercortisolism can be sporadic or can occur in the context of familial disease because of pituitary or extra-pituitary neuroendocrine tumors.
William F. Simonds
doaj   +1 more source

Pituitary blastoma, expanding the spectrum of newly recognized entities. A case report

Indian Journal of Pathology and Microbiology, 2022
Tumors of the pituitary gland and sellar region represent about 15% of all brain tumors, with pituitary adenoma being the commonest and pituitary carcinoma being very rare. Pituitary tumors in children are even rarer.
Meenakshi Swain, Sundaram Challa, Subodh Raju   +2 more
doaj   +1 more source

Cyclooxygenase enzyme and PGE2 expression in patients with functional and non-functional pituitary adenomas

BMC Endocrine Disorders, 2020
Background Pituitary adenomas as multifactorial intracranial neoplasms impose a massive burden of morbidity on patients and characterizing the molecular mechanism underlying their pathogenesis has received considerable attention.
Nasrin Akbari, Mohammad Ghorbani, Vahid Salimi, Alimohammad Alimohammadi, Mohammad E. Khamseh, Hamideh Akbari, Mitra Nourbakhsh, Alireza Sheikhi, S. Fahimeh Taghavi, Masoumeh Tavakoli-Yaraki   +9 more
doaj   +1 more source

Coexistence of Pituitary Adenoma and Primary Pituitary Lymphoma: A Case Report and Review of the Literature

Frontiers in Surgery, 2022
In the pituitary sella, the coexistence of pituitary adenoma and primary pituitary lymphoma is exceedingly rare. Thus far, only six cases have been reported. Here, we present the seventh case of coexisting pituitary adenoma and primary pituitary lymphoma,
Shangjun Ren, Qingyang Lu, Yilei Xiao, Yiming Zhang, Lianqun Zhang, Bin Li, Mengyou Li   +6 more
doaj   +1 more source

Corticotroph Aggressive Pituitary Tumors and Carcinomas Frequently Harbor ATRX Mutations

Journal of Clinical Endocrinology and Metabolism, 2020
Context Aggressive pituitary tumors (APTs) are characterized by unusually rapid growth and lack of response to standard treatment. About 1% to 2% develop metastases being classified as pituitary carcinomas (PCs).
O. Casar-Borota, H. Boldt, B. Engström, M. Andersen, B. Baussart, D. Bengtsson, K. Berinder, B. Ekman, U. Feldt-Rasmussen, C. Höybye, J. Jørgensen, A. Kolnes, M. Korbonits, Å. Rasmussen, J. Lindsay, P. Loughrey, D. Maiter, E. Manojlović-Gačić, J. Pahnke, P. L. Poliani, V. Popović, O. Ragnarsson, C. Schalin-Jäntti, D. Scheie, M. Tóth, C. Villa, M. Wirenfeldt, J. Kunicki, P. Burman   +28 more
semanticscholar   +1 more source